| 2024/05/10 08:15:08 | |
|---|---|
| Price | |
| 0.822 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | NL00150002Q7 |
| Symbol | VVY |
| Exchange | Munich |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 21 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 0.792 EUR (700) |
| Ask (Ask size) | 0.802 EUR (700) |
| Open | 0.822 EUR |
| High | 0.822 EUR |
| Low | 0.822 EUR |
| Close (prev. day) | 0.822 EUR |
| VWAP | 0.548 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: VIVORYON THERAPEUTICS AG |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/05/10 08:15:08 | |
|---|---|
| Price | |
| 0.822 EUR | |
| Difference | 0.00% (0.00) |
General attributes
| ISIN | NL00150002Q7 |
| Symbol | VVY |
| Exchange | Munich |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 21 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 0.792 EUR (700) |
| Ask (Ask size) | 0.802 EUR (700) |
| Open | 0.822 EUR |
| High | 0.822 EUR |
| Low | 0.822 EUR |
| Close (prev. day) | 0.822 EUR |
| VWAP | 0.548 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 1 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -89.21% | -95.70% | -94.31% |
| Perf (abs.) | -6.80 | -18.28 | -13.62 |
| Beta | 3.54 | 2.12 | 1.24 |
| Volatility | 362.42 | 256.77 | 155.17 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 0.766 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.617 EUR (7) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 4.856 EUR (1,851) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 8.732 EUR (773) |
| YTD High | date | 10.040 EUR (2024/02/19) |
| YTD Low | date | 0.448 EUR (2024/04/18) |
| 52 Weeks High | date | 19.400 EUR (2023/05/10) |
| 52 Weeks Low | date | 0.448 EUR (2024/04/18) |
All listings for VIVORYON THERAPEUTICS AG
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/05/10 | 10:56 | 0.791 EUR | 0.00 | 4 |
| Stuttgart | 2024/05/10 | 10:30 | 0.778 EUR | 0.00 | 4 |
| Munich | 2024/05/10 | 08:15 | 0.822 EUR | 0.00 | 1 |
| London Stock Exchange | 2024/02/02 | 16:10 | 8.313 EUR | 0.02 | 1 |
| Frankfurt | 2024/05/10 | 08:20 | 0.791 EUR | 0.00 | 1 |
| Euronext Amsterdam | 2024/05/10 | 11:10 | 0.793 EUR | 0.14 | 118 |
| Duesseldorf | 2024/05/10 | 08:11 | 0.799 EUR | 0.00 | 1 |
| Berlin | 2024/05/10 | 10:55 | 0.794 EUR | 0.00 | 5 |
Company Logo
Contact Details
| VIVORYON THERAPEUTICS NV |
| - - |
| Weinbergweg 22 - 06120 Halle |
| Telefon: +49-345-555-99-00 |
| Fax: + |
| E-mail: info@vivoryon.com |
PDF Downloads
| Company report: VIVORYON THERAPEUTICS AG | |
Company Profile
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany. |
Members of Management Board
| Frank Weber | Chairman of Managing Board |
| Michael Schaeffer | Member of Executive Committee |
| Anne Doering | Member of Executive Committee |
| Florian Schmid | Member of Executive Committee |
Board of directors
| Erich Maximilian Platzer | Chairman of Supervisory Board |
| Claudia Riedl | Member of Supervisory Board |
| Michael Schaeffer | Member of Supervisory Board |
| Samir Shah | Member of Supervisory Board |
| Anne Doering | Member of Supervisory Board |
| Charlotte Lohmann | Member of Supervisory Board |